Table 3.

Fatty acid composition of mitochondrial phospholipids expressed as a percent of total phospholipid fatty acids

Fatty acid	Untreated		DHA treated
	Sham	Heart failure	Sham	Heart failure
SSM
14:0	0.58±0.11	0.65±0.10	0.60±0.10	0.68±0.07
16:0	25.9±1.7	31.9±2.8^	27.4±2.1	30.8±1.1
16:1	0.32±0.05	0.39±0.04	1.3±0.7	0.31±0.05
18:0	39.8±3.1	37.4±2.2	31.3±3.7	37.2±1.1
18:1n9	5.5±0.3	4.5±0.5	5.1±0.3	6.1±0.4
18:1n7	2.7±0.3	3.6±0.4	2.4±0.2	3.1±0.2
18:2n6	15.5±2.0	9.0±1.2&	17.8±1.1	11.3±1.0&
18:3n3	0.14±0.01	0.12±0.01	0.40±0.20	0.11±0.01
20:3n6	0.04±0.00	0.04±0.01	0.24±0.13	0.06±0.00
20:5n3	0.01±0.00	0.01±0.00	0.15±0.02†	0.13±0.01†
22:5n3	0.17±0.02	0.16±0.02	0.12±0.02†	0.08±0.01†
Σ n6-PUFA	24.2±3.1	18.8±2.2	21.4±1.4	14.9±1.1^
Σ n3-PUFA	1.8±0.3	1.8±0.2	10.3±1.6†	6.9±0.7†^
Σ MUFA	8.8±0.5	9.4±0.8	8.9±0.7	9.5±0.4
Σ SFA	65.3±3.3	69.9±2.8	59.3±3.4	68.6±1.8
IFM
14:0	0.52±0.06	0.56±0.11	0.55±0.06	0.45±0.04
16:0	26.3±1.6	29.1±1.2^	31.1±1.5	30.1±1.1
16:1	0.39±0.02	0.44±0.04	0.33±0.05	0.39±00.3
18:0	29.1±2.7	30.4±2.1	29.1±2.1	29.5±1.8
18:1n9	8.5±0.6	6.2±0.7	6.6±0.7	6.8±0.3
18:1n7	3.8±0.6	7.0±0.4	3.3±0.4	4.5±0.3
18:2n6	21.8±3.1	12.4±1.4&	18.1±12.0	15.7±1.7
18:3n3	0.04±0.03	0.07±0.03	0.07±0.02	0.07±0.02
20:3n6	0.04±0.01	0.05±0.01	0.07±0.03	0.08±0.01
20:5n3	0.01±0.00	0.01±0.02	0.13±0.02†	0.17±0.02†
22:5n3	0.20±0.03	0.28±0.03	0.15±0.03	0.11±0.01†
Σ n6-PUFA	29.4±2.9	23.5±2.1	21.9±2.2*	20.1±1.8
Σ n3-PUFA	1.8±0.4	2.7±0.3	7.0±0.9†	8.3±0.8†
Σ MUFA	12.7±1.1	13.7±1.0	10.3±0.8	11.7±0.5
Σ SFA	55.9±4.1	60.1±3.3	60.7±3.4	60.0±2.7

^*P <0.05,

^†P <0.001 compared to the standard diet within the respective surgical treatment group.

^{^}P <0.05,

^&P <0.005 compared to respective sham within diet group

Groups sizes were 10 and 12 for the untreated sham and heart failure groups, respectfully, and 10 and 12 for the DHA treated sham and heart failure groups, respectfully